Inventors:
Bregman; William (Miami Beach, FL)
Assignee:
Advanced Viral Research Corp. (Hallandale, FL)
Appl. No.:
835792
Filed:
April 15, 1997
U.S. Class:
514/2; 514/21; 514/44; 514/885
Intern'l Class:
A61K 38//01; .31/70
Field of Search:
514/2,44,885,21 424/78.02,78.03,78.05,78.08
References Cited [Referenced By]
U.S. Patent Documents
4619913
Oct., 1986
Luck et al.
514/2.
5130247
Jul., 1992
Kniskern et al.
435/254.
5194245
Mar., 1993
Carter
424/9.
Other References
Ragni et al., Blood, 81:1889-1897, 1993.
Reynolds, Margaret R., Generalized Vaccinia, Symposium, pp. 5-6, 1960.
Kuckku, Morris E., Herpetic Diseases, Symposium, pp. 7-13, 1960.
Schaeffer, Oden A., Influenza, Symposium, pp. 15-21, 1960.
Seydel, Frank, Epidemic, Asian Influenza, Symposium, pp. 23-24, 1960.
Cooke, Stanford B., Upper Respiratory Viral Manifestations, Clinical Symposium on Viral Diseases
Demonstrating the Anti-viral Biotic Properties of the Drug Reticulose (Symposium), Sep., 1960, Miami Beach,
Florida, pp. 25-32.
Medoff, Lawrence R., Infectious Mononucleosis, Symposium, pp. 33-37, 1960.
Anderson, Robert H., Encephalitis, Symposium, pp. 39-52, 1960.
Plucinski, Stanisloff J., Suspected Viral Varieties, Symposium, pp. 53-59, 1960.
Kosaka, K. and Shimada, Y., Infectious Hepatitis, Symposium, pp. 61-74, 1960.
Anderson, Robert H. and Thompson, Ralph M., Treatment of Viral Syndrome with a Lipoprotein-Nucleic Acid
Compound (Reticulose), A Report of Five Cases, Virginia Medical Monthly, 84: 347-353, 1957.
Reynolds, Margaret R., Generalized Vaccinia Successfully Treated With Lipoprotein-Nucleic Acid Complex
(Reticulose), Archives of Pedratrics, 77:421-422, 1960.
Wegryn, Stanley P., Marks, Robert A. and Baugh, John R., Herpes Gestationis, A Report of 2 Cases,
American Journal of Obstetrics and Gynecology, 79:812-814, 1960.
Catterall, R.A., Lumpur, Kuala, A New Treatment of Herpes Zoster, Vaccinia And Chicken Pox, J. Roy, Coll.
Gen. Practit., 1970, 19, 182.
Chinnici, Angelo A., Reticulose in Treatment Aids patients, Personal Communication to William Bregman, Jul.
6, 1992.
Cott, Rafael A., Summary of 11 Cases of Viral Infections with Reticulose, Private Communication with
Advance Viral Research Corp., 1989.
Cohen, Matthew, The Efficacy of a Peptide-Nucleic Acid Solution (Reticulose) for the Treatment of Hepatitis
A and Hepatitis B--a Preliminary Controlled Human Clinical Trial, J. Roy Soc. Health, Dec., 1992, 266-270.
Mundschenk, David D., In Vitro Antiviral Activity of Reticulose vs Influenaz A, Personal Communication with
William Bregman, May 1, 1990.
Resnick, Lionel, Anti-HIV in Vitro Activity of Two Samples of Peptide-nucleic Acid Solution, Personal
Communication with Dr. Bernard Friedland, Dec. 22, 1989.
Friedland, Bernard, In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human
Immunodeficiency Virus and Influenza A Virus, J. Roy. Soc. Health, Oct. 1991, 170-171.
Brazier, Anne D., Method for in Vitro Antiviral Evaluation Human Immunodeficiency Virus (HIV), Personal
Communication with Dr. Bernard Friedland, Oct. 4, 1989.
Behbehani, Abbas M., Haberman Sol and Race, George J, The Effect of Reticulose on Viral Infections of
Experimental Animals, Southern Medical Journal, Feb., 1962, 185-188.
Treatment of Viral Diseases with A Lipo-protein Nucleic Acid Complex (Reticulose)--A Clinical Study,
Scientific Exhibit: Virginia State Medical Society Meeting, Washington D.C., Nov., 1957.
Kempe, Henry C., Fulginiti, Vincent A., and Vincent, Leone St., Failure to Demonstrate Antiviral Activity of
Reticulose, Diseases of Children, vol. 103, No. 5, 655-657, 1962.
Sanders, Murray, Controlled Animal Studies with Reticulose Illustrating of Lipoprotein-Nucleic Acid Complex
in the Experimental Animal Infected with Human Pathogenic Viral Entities, Southern Medical Association
Scientific Exhibit, Dallas, Texas, Nov., 1961.
Primary Examiner: Wityshyn; Michael G.
Assistant Examiner: Kerr; Janet M.
Attorney, Agent or Firm: Cohen, Pontani, Lieberman & Pavane |
